ProMab Biotechnologies, Inc. a Corporate Support Sponsor for the San Francisco Molecular Med Tri-Con 2013

Published: Dec 11, 2012

December 10, 2012 -- ProMab Biotechnologies, Inc. a biotechnology company specializing in custom monoclonal antibodies, monoclonal antibody services, and protein expression services is proud to be a corporate support sponsor for the annual 2013 San Francisco Molecular Med Tri-Con. Be sure to join us along with thousands of other top scientists and executives at the conference celebrating 20 years of advancing applied science and technology.

Register at

Back to news